Harvard Bioscience, Inc.
HBIO
$0.3769
-$0.013-3.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.09% | 12.87% | -4.86% | -0.65% | -19.79% |
| Total Receivables | 15.86% | 2.76% | -18.44% | -4.91% | 7.45% |
| Inventory | -10.56% | 3.42% | 4.12% | -2.35% | -4.27% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -14.79% | -28.64% | 7.15% | 12.89% | -9.32% |
| Total Current Assets | -3.58% | 0.78% | -3.57% | -1.81% | -2.87% |
|
|
|||||
| Total Current Assets | -3.58% | 0.78% | -3.57% | -1.81% | -2.87% |
| Net Property, Plant & Equipment | -4.31% | 27.96% | 3.69% | 1.11% | 3.98% |
| Long-term Investments | -1.94% | 1.43% | -0.13% | -0.64% | 1.50% |
| Goodwill | -1.94% | 1.43% | -0.13% | -0.64% | 1.50% |
| Total Other Intangibles | -9.80% | -8.18% | -8.43% | -8.47% | -6.19% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.11% | -8.68% | 3.79% | 3.77% | -60.43% |
| Total Assets | -3.50% | 1.81% | -3.19% | -3.06% | -1.70% |
|
|
|||||
| Total Accounts Payable | -9.39% | -7.49% | -5.51% | 8.82% | -11.41% |
| Total Accrued Expenses | -17.25% | -0.94% | -26.09% | -15.79% | 11.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 705.28% | -0.94% | -2.83% | -32.41% | 30.03% |
| Total Finance Division Other Current Liabilities | -2.07% | 6.71% | -14.66% | 18.33% | 10.95% |
| Total Other Current Liabilities | -2.07% | 6.71% | -14.66% | 18.33% | 10.95% |
| Total Current Liabilities | 141.56% | 0.57% | -11.90% | -3.26% | 9.66% |
|
|
|||||
| Total Current Liabilities | 141.56% | 0.57% | -11.90% | -3.26% | 9.66% |
| Long-Term Debt | -- | 7.87% | 0.22% | 3.19% | -12.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.85% | 42.29% | 3.42% | -4.94% | 8.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.01% | -16.28% | 6.56% | 8.38% | 32.20% |
| Total Liabilities | -3.96% | 6.90% | -4.17% | 0.09% | -1.77% |
|
|
|||||
| Common Stock & APIC | 0.26% | 0.45% | 0.62% | 0.44% | -0.21% |
| Retained Earnings | 0.01% | -3.13% | -1.95% | -3.22% | -1.26% |
| Treasury Stock & Other | -19.99% | 12.17% | -0.64% | -4.12% | 7.13% |
| Total Common Equity | -3.03% | -2.86% | -2.27% | -5.83% | -1.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.03% | -2.86% | -2.27% | -5.83% | -1.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.03% | -2.86% | -2.27% | -5.83% | -1.63% |
|
|
|||||